Kirk's promotion to captain in the Kelvin Timeline made very little sense, but Chakotay's journey at least means it's not an ...
New three-month data from a study of non-human primates underpins the biotech firm's decision to amend the small interfering RNA program.
The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...
Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs ...